呼吁弥合乳房再造研究中的学科鸿沟:一项系统综述
该研究系统综述2000至2019年乳房再造结局研究,评估多学科参与度。筛选1679篇后纳入784篇,仅50.6%有整形外科以外作者。多学科研究更易获高证据等级(p<0.001)、高影响因子期刊发表(p<0.05)及更高使用量(p=0.03)和提及量(p=0.02)。
要点
- 乳房再造结局研究中仅半数有整形外科以外学科作者参与。
- 多学科参与与更高证据等级、更高影响因子及更高使用量相关。
- 建议加强乳房再造研究中的多学科协作以提升研究质量与影响力。
核心结论
- 乳房再造结局研究常缺乏非整形外科作者的协作。
- 强烈建议在乳腺癌护理研究中引入多学科参与,以提高临床研究的质量与影响力。
研究设计与样本
- 系统综述,检索Ovid MEDLINE、Ovid EMBASE和PubMed数据库中2000至2019年发表的英文文献。
- 纳入标准为北美或欧洲发表、非儿科患者n≥12、涉及乳房再造的研究。
- 排除非乳腺癌护理背景的手术或未评估至少一个结局、诊断测试或风险因素的文章。
- 通过作者单位定义多学科参与,并用证据等级、期刊影响因子和altmetrics评估研究质量。
主要发现
- 共筛选1679篇文章,784篇符合纳入标准。
- 仅50.6%的文章有整形外科以外的作者参与。
- 多学科研究更可能被指定为较高证据等级(I或II级)(p<0.001)。
- 多学科研究更可能发表在较高影响因子期刊(p<0.05),具有更高使用量(p=0.03)和提及量(p=0.02)。
- 引用、收藏和社交媒体帖子方面无差异(p>0.05)。
临床怎么用
- 开展乳房再造结局研究时应主动纳入非整形外科作者以促进多学科协作。
- 多学科参与可能提升研究证据等级、期刊影响力及传播效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Breast reconstruction is an important component of comprehensive breast cancer care. Although reconstructive plans require multidisciplinary clinical-decision making, research in cross-discipline collaborations is often limited. This study aims to evaluate multidisciplinary involvement in breast reconstruction outcomes research. METHODS: A systematic review of breast reconstruction literature published from 2000 to 2019 using Ovid MEDLINE, Ovid EMBASE, and PubMed databases was conducted. English language articles published in North America or Europe with n ≥ 12 nonpediatric patients were included. Articles concerning procedures not performed in the context of breast cancer care or articles that did not evaluate at least one outcome, diagnostic test, or risk factor were excluded. Authors' affiliations were used to define multidisciplinary involvement. Quality of research was evaluated using the level of evidence, journal impact factor (IF), and altmetrics. RESULTS: Of the 1679 articles screened, 784 met the stated eligibility criteria. Only half (50.6%) of these articles involved an author outside the discipline of plastic surgery. Compared to nonmultidisciplinary studies, multidisciplinary studies were more likely to be designated with a higher level of evidence (I or II) (p<0.001), published in journals with higher IF (p<0.05), have higher usage (p = 0.03), and mentions (p = 0.02). There was no difference in citations, captures, and social media posts (p>0.05). CONCLUSION: Breast reconstruction outcomes research often fails to offer author collaborations from nonplastic surgery disciplines. Multidisciplinary involvement in breast cancer care research is strongly recommended to improve the quality and impact of clinical studies in breast reconstruction.
引用
- Hsiang Shawn Yuan P, Xu R, Maclean L, et al. A call to bridge the divide in breast reconstruction research: A systematic review. J Plast Reconstr Aesthet Surg. 2021. PMID: 34301512. doi:10.1016/j.bjps.2021.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。